1. Report Overview
1.1 Global Erythropoietin Market Overview
1.2 Overview of Findings
1.3 Structure of the Report
1.4 Global Erythropoietin Market Segmentation
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Who is This Report For?
1.9 Methodology
1.10 Associated Visiongain Reports
1.11 About Visiongain

2. Introduction to Erythropoietin
2.1 An Introduction to Erythropoietin
2.1.1. Epoetin Alfa
2.1.2. Epoetin Beta
2.1.3. Darbepoetin Alfa
2.1.4. Biosimilars
2.2. Erythropoietin Market: Drivers, Restraints and Opportunities
2.2.1.Drivers
2.2.1.1.Growing incidence of renal diseases
2.2.1.2. Increasing Prevalence of Caner
2.2.1.3. Higher incidence of chronic and multiple diseases, especially diabetes
2.2.2.Restraints
2.2.2.1. Side effects of Erythropoietin
2.2.2.2. Limitations of Use
2.2.3. Opportunities
2.2.3.1. Changing regulatory landscape and emerging healthcare reforms
2.3. List of promising candidates

3. Global Erythropoietin Market 2017-2027
3.1 Global Erythropoietin Market Forecast 2017-2027
3.2 Changing Market Shares by Segment 2017-2027
3.3 Global Epoetin Alfa Market: Sales Forecast 2017-2027
3.3.1. Leading Products in the Epoetin Alfa Market
3.3.1.1.EPOGEN (Amgen, Inc.)
3.3.1.2.PROCRIT/EPREX (Johnson & Johnson)
3.3.2. SWOT Analysis of the Epoetin Alfa Market, 2017-2027
3.3.2.1. Strength
3.3.2.1.1. Good reimbursement availability
3.3.2.2. Weakness
3.3.2.2.1. Side effects of Epoetin alfa
3.3.2.2.2. Limitations of Use
3.3.2.3. Opportunity
3.3.2.3.1. Increasing demand to address anemia in chronic diseases
3.3.2.4. Threat
3.3.2.4.1. Introduction of biosimilars of the off-patented brands
3.4 Global Epoetin Beta Market: Sales Forecast 2017-2027
3.4.1. Leading Products in the Epoetin Beta Market
3.4.1.1. Mircera (F. Hoffmann-La Roche AG)
3.4.1.2.NeoRecormon (F. Hoffmann-La Roche AG)
3.4.2. SWOT Analysis of the Epoetin Beta Market, 2017-2027
3.4.2.1. Strength
3.4.2.1.1.Leading brand Mircera launched in the U.S.
3.4.2.2. Weakness
3.3.2.2.1.Mircera is not a preferred brand of the Payers
3.4.2.3. Opportunity
3.4.2.3.1.Increased incidences of kidney failures
3.4.2.4. Threat
3.4.2.4.1.Availability of cost effective biosimilars
3.5 Global Darbepoetin Alfa Market: Sales Forecast 2017-2027
3.5.1. Leading Products in the Darbepoetin Alfa Market
3.5.1.1. Aranesp (Amgen, Inc.)
3.5.2. SWOT Analysis of the Darbepoetin Alfa Market, 2017-2027
3.5.2.1. Strength
3.5.2.1.1. Aranesp – Patent Expiry in the US
3.5.2.2. Weakness
3.5.2.2.1. Aranesp – Patent Expiry in Europe
3.5.2.3. Opportunity
3.5.2.3.1.Increased incidences of kidney failures
3.5.2.4. Threat
3.5.2.4.1. Availability of biosimilars
3.6 Global Biosimilars Beta Market: Sales Forecast 2017-2027
3.6.1. Leading Products in the Biosimilars Market
3.6.1.1.Retacrit (Hospira)
3.6.1.2.EPIAO (3SBio Inc.)
3.6.1.3.Epoetin Alfa BS ( Japan Chemical Research Pharmaceuticals Co., Ltd.)
3.6.1.4.Espogen (LG Life Sciences Ltd)
3.6.2. SWOT Analysis of the Biosimilars Market, 2017-2027
3.6.2.1. Strength
3.6.2.1.1. Lower cost structure
3.6.2.2. Weakness
3.6.2.2.1.Lack of credibility in the prescribing community
3.6.2.3. Opportunity
3.6.2.3.1.Favourable pricing and reimbursement policies
3.6.2.3.2.Driving further innovation
3.6.2.4. Threat
3.6.2.4.1.Evolving regulatory environment against the industry's interests
3.7 Global Erythropoietin Market, by Application: Sales Forecast 2016-2027
3.7.1 Changing Market Shares by Segment 2017-2027
3.7.2 Global Anemia: Sales Forecast 2016-2027
3.7.3 Global Kidney Disorder: Sales Forecast 2016-2027
3.7.4 Global Others Segment: Sales Forecast 2016-2027

4. Global Active pharmaceutical ingredients (API) Manufacturing of Erythropoietin Market 2017-2027
4.1 Changing Market Shares by Segment 2017-2027
4.2.Contract API Manufacturing Market Forecast 2017-2027
4.3. In-house API Manufacturing Market Forecast 2017-2027

5.Leading National Markets 2017-2027
5.1.Geographical Breakdown of the World Erythropoietin Market
5.2 World Erythropoietin Market: Regional Forecast 2017-2027
5.2.1 How Will Regional Market Shares Change to 2027?

6.North America Erythropoietin Market 2017-2027
6.1. US Erythropoietin Market Forecast 2017-2027
6.2. Canada Erythropoietin Market Forecast 2017-2027

7. Europe Erythropoietin Market 2017-2027
7.1. Germany Erythropoietin Market Forecast 2017-2027
7.2. France Erythropoietin Market Forecast 2017-2027
7.3. U.K. Erythropoietin Market Forecast 2017-2027
7.4.Italy Erythropoietin Market Forecast 2017-2027
7.5.Spain Erythropoietin Market Forecast 2017-2027
7.6.Rest of Europe Erythropoietin Market Forecast 2017-2027

8.Asia Pacific Erythropoietin Market 2017-2027
8.1. China Erythropoietin Market Forecast 2017-2027
8.2. Japan Erythropoietin Market Forecast 2017-2027
8.3. India Erythropoietin Market Forecast 2017-2027
8.4.Rest of Asia Pacific Erythropoietin Market Forecast 2017-2027

9. Latin America Erythropoietin Market 2017-2027
9.1 Brazil Erythropoietin Market Forecast 2017-2027
9.2 Mexico Erythropoietin Market Forecast 2017-2027
9.3 Rest of Latin America Erythropoietin Market Forecast 2017-2027

10. Middle East and Africa Erythropoietin Market 2017-2027
10.1. Saudi Arabia Erythropoietin Market Forecast 2017-2027
10.2. South Africa Erythropoietin Market Forecast 2017-2027
10.3.Rest of Middle East and Africa Erythropoietin Market Forecast 2017-2027

11. Leading Companies in the Erythropoietin Market
11.1. Amgen, Inc.
11.1.1 Amgen, Inc. Corporation: Erythropoietin Product Portfolio
11.1.2 Financial Overview
11.1.2.Recent Transactions Summary
11.2. Johnson & Johnson
11.2.1. Johnson & Johnson: Erythropoietin Product Portfolio
11.1.2 Financial Overview
11.2.3.Recent Transactions Summary
11.3. F. Hoffmann-La Roche AG
11.3.1 Roche: Erythropoietin Product Portfolio
11.3.2 Roche: Financial Overview
11.3.3.Recent Transactions Summary
11.4. Biocon Ltd.
11.4.1 Biocon: Erythropoietin Product Portfolio
11.4.2 Biocon: Financial Overview
11.4.3 Biocon: Recent Developments
11.5. 3SBio, Inc.
11.5.1 3SBio: Erythropoietin Product Portfolio
11.5.2 3SBio: Financial Overview
11.5.3 3SBio: Recent Developments
11.6. Pfizer, Inc.
11.6.1 Pfizer, Inc.: Erythropoietin Product Portfolio
11.6.2 Pfizer, Inc.: Financial Overview
11.6.3 Pfizer, Inc.: Recent Developments
11.7. Kyowa Hakko Kirin Co Ltd.
11.7.1 Kyowa Hakko Kirin Co Ltd.: Erythropoietin Product Portfolio
11.7.2 Kyowa Hakko Kirin Co Ltd.: Financial Overview
11.7.3 Kyowa Hakko Kirin Co Ltd.: Recent Developments
11.8. LG Life Sciences Limited
11.8.1 LG Life Sciences Limited: Erythropoietin Product Portfolio
11.8.2 LG Life Sciences Limited: Financial Overview
11.8.3 LG Life Sciences Limited: Recent Developments
11.9. Intas Pharmaceuticals Ltd.
11.7.1 Intas Pharmaceuticals Ltd.: Erythropoietin Product Portfolio
11.7.2 Intas Pharmaceuticals Ltd.: Recent Developments
11.7. Novartis AG
11.7.1 Novartis AG: Erythropoietin Product Portfolio
11.7.2 Novartis AG: Financial Overview
11.7.3 Novartis AG: Recent Developments

12. Conclusions
12.1 The World Erythropoietin Market in 2016 and 2017
12.1.1 Current Leading Erythropoietin Segments
12.1.3 Leading Regional Markets
12.2 World Erythropoietin Market Forecast 2017-2027

Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain Report Evaluation Form

List of Tables
Table 2.1 Top 10 countries for cancer frequency by country
Table 2.2 Top 10 countries for numbers of people aged 20–79 years with diabetes in 2011 and 2030
Table: 2.3. List of Promising Candidates Phase II
Table 2.4: List of Promising Candidates Phase III
Table 3.1 Global Erythropoietin Market by Product Type: Revenue ($m) and Market Share (%), 2016
Table 3.2 Global Erythropoietin Market Forecast, By Product Type: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 3.3 Global Epoetin Alfa Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 3.4 Global EPOGEN Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 3.5 Global PROCRIT/EPREX Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 3.6 SWOT Analysis of the Epoetin Alfa Market, 2017-2027
Table 3.7 Global Epoetin Beta Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 3.8 Global Mircera Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 3.9 Global NeoRecormon Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 3.10 SWOT Analysis of the Epoetin Beta Market, 2017-2027
Table 3.11 Global Darbepoetin Alfa Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 3.12 Global Aranesp Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 3.13 SWOT Analysis of the Darbepoetin Alfa Market, 2017-2027
Table 3.14 Global Biosimilars Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 3.15 Global Retacrit Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 3.16 Global EPIAO Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 3.17 Global Epoetin Alfa BS Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 3.18 Global Espogen Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 3.19 SWOT Analysis of the Biosimilars Market, 2017-2027
Table 3.20 Global Erythropoietin Market Forecast, By Application: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 3.21 Global Anemia Forecast: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 3.22 Global Kidney Disorders Forecast: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 3.23 Global Others: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 4.1 Global Erythropoietin API Manufacturing Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 4.2 Global Contract Erythropoietin API Manufacturing Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 4.3 Global In-house Erythropoietin API Manufacturing Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 5.1 Global Erythropoietin Market by Region: Revenue ($m), 2015 and 2016
Table 5.2 World Erythropoietin Market Forecast: Revenues ($m), AGR (%), CAGR (%) by Region, 2015-2027
Table 6.1 North America Erythropoietin Market Forecast, By Product Type: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 6.2 North America Erythropoietin Market Forecast, By Application: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 6.3 North America Erythropoietin Market Forecast, By Country, 2015-2027 ($m, AGR %, CAGR %)
Table 6.4 US Erythropoietin Market Forecast, By Country, 2015-2027 ($m, AGR %, CAGR %)
Table 6.5 Canada Erythropoietin Market Forecast, By Country, 2015-2027 ($m, AGR %, CAGR %)
Table 7.1 Europe Erythropoietin Market Forecast, By Product Type: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 7.2 Europe Erythropoietin Market Forecast, By Application: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 7.3 Europe Erythropoietin Market Forecast, By Country, 2015-2027 ($m, AGR %, CAGR %)
Table 7.4 Germany Erythropoietin Market Forecast, By Country, 2015-2027 ($m, AGR %, CAGR %)
Table 7.5 France Erythropoietin Market Forecast, By Country, 2015-2027 ($m, AGR %, CAGR %)
Table 7.6 U.K. Erythropoietin Market Forecast, By Country, 2015-2027 ($m, AGR %, CAGR %)
Table 7.7 Italy Erythropoietin Market Forecast, By Country, 2015-2027 ($m, AGR %, CAGR %)
Table 7.8 Spain Erythropoietin Market Forecast, By Country, 2015-2027 ($m, AGR %, CAGR %)
Table 7.9 Rest of Europe Erythropoietin Market Forecast, 2015-2027 ($m, AGR %, CAGR %)
Table 8.1 Asia Pacific Erythropoietin Market Forecast, By Product Type: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 8.2 Asia Pacific Erythropoietin Market Forecast, By Application: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 8.3 Asia Pacific Erythropoietin Market Forecast, By Country, 2015-2027 ($m, AGR %, CAGR %)
Table 8.4 China Erythropoietin Market Forecast, By Country, 2015-2027 ($m, AGR %, CAGR %)
Table 8.5 Japan Erythropoietin Market Forecast, By Country, 2015-2027 ($m, AGR %, CAGR %)
Table 8.6 India Erythropoietin Market Forecast, By Country, 2015-2027 ($m, AGR %, CAGR %)
Table 8.7 Rest of Asia Pacific Erythropoietin Market Forecast, By Country, 2015-2027 ($m, AGR %, CAGR %)
Table 9.1 Latin America Erythropoietin Market Forecast, By Product Type: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 9.2 Latin America Erythropoietin Market Forecast, By Application: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 9.3 Latin America Erythropoietin Market Forecast, By Country, 2015-2027 ($m, AGR %, CAGR %)
Table 9.4 Brazil Erythropoietin Market Forecast, By Country, 2015-2027 ($m, AGR %, CAGR %)
Table 9.5 Mexico Erythropoietin Market Forecast, By Country, 2015-2027 ($m, AGR %, CAGR %)
Table 9.6 Rest of Latin America Erythropoietin Market Forecast, By Country, 2015-2027 ($m, AGR %, CAGR %)
Table 10.1 Middle East and Africa Erythropoietin Market Forecast, By Product Type: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 10.2 Middle East and Africa Erythropoietin Market Forecast, By Application: Revenues ($m), AGR (%), CAGR (%), 2015-2027
Table 10.3 Middle East and Africa Erythropoietin Market Forecast 2015-2027 ($m, AGR %, CAGR %)
Table 10.4 Saudi Arabia Erythropoietin Market Forecast, By Country, 2015-2027 ($m, AGR %, CAGR %)
Table 10.5 South Africa Erythropoietin Market Forecast, By Country, 2015-2027 ($m, AGR %, CAGR %)
Table 10.6 Rest of MEA Erythropoietin Market Forecast, By Country, 2015-2027 ($m, AGR %, CAGR %)
Table 11.1 Amgen, Inc.Corporation: Overview, 2017
Table 11.2 Amgen, Inc.: Revenue ($m), AGR (%), 2011-2015
Table 11.3.Johnson & Johnson: Overview, 2017
Table 11.4 Johnson & Johnson: Revenue ($m), AGR (%), 2011-2015
Table 11.5 Roche: Overview, 2017
Table 11.6 Roche: Revenue ($m), AGR (%), 2011-2015
Table 11.7 Biocon: Overview, 2017
Table 11.8 Biocon: Revenue ($m), AGR (%), 2012-2016
Table 11.9 3SBio: Overview, 2017
Table 11.10 3SBio: Revenue ($m), AGR (%), 2011-2015
Table 11.11 Pfizer, Inc.: Overview, 2017
Table 11.12 Pfizer, Inc.: Revenue ($m), AGR (%), 2011-2015
Table 11.13 Kyowa Hakko Kirin Co Ltd: Overview, 2017
Table 11.14 Kyowa Hakko Kirin Co Ltd: Revenue ($m), AGR (%), 2011-2015
Table 11.15 LG Life Sciences Limited: Overview, 2017
Table 11.16 LG Life Sciences Limited: Revenue ($m), AGR (%), 2011-2015
Table 11.17 Intas: Overview, 2017
Table 11.18 Novartis: Overview, 2017
Table 11.19 Novartis: Revenue ($m), AGR (%), 2012-2016

List of Figures
Figure 1.1 Global Erythropoietin Market Segmentation Overview
Figure 3.1 Global Erythropoietin Market by Product Type: Market Share (%), 2016
Figure 3.2 Global Erythropoietin Market Forecast: Revenue ($m), AGR (%), 2015-2027
Figure 3.3 Global Erythropoietin Market by Product Type: Market Share (%), 2016
Figure 3.4 Global Erythropoietin Market by Product Type: Market Share (%), 2021
Figure 3.5 Global Erythropoietin Market by Product Type: Market Share (%), 2027
Figure 3.6 Global Epoetin Alfa Forecast: Revenue ($m), AGR (%), 2015-2027
Figure 3.7 Global EPOGEN Forecast: Revenue ($m), AGR (%), 2015-2027
Figure 3.8 Global PROCRIT/EPREX Forecast: Revenue ($m), AGR (%), 2015-2027
Figure 3.9 Global Epoetin Beta Forecast: Revenue ($m), AGR (%), 2015-2027
Figure 3.10 Global Mircera Forecast: Revenue ($m), AGR (%), 2015-2027
Figure 3.11 Global NeoRecormon Forecast: Revenue ($m), AGR (%), 2015-2027
Figure 3.12 Global Darbepoetin Alfa Forecast: Revenue ($m), AGR (%), 2015-2027
Figure 3.13 Global Aranesp Forecast: Revenue ($m), AGR (%), 2015-2027
Figure 3.14 Global Biosimilars Forecast: Revenue ($m), AGR (%), 2015-2027
Figure 3.15 Global Retacrit Forecast: Revenue ($m), AGR (%), 2015-2027
Figure 3.16 Global EPIAO Forecast: Revenue ($m), AGR (%), 2015-2027
Figure 3.17 Global Epoetin Alfa BS Forecast: Revenue ($m), AGR (%), 2015-2027
Figure 3.18 Global Espogen Forecast: Revenue ($m), AGR (%), 2015-2027
Figure 3.19 Global Erythropoietin Market by Application: Market Share (%), 2016
Figure 3.20 Global Erythropoietin Market by Application: Market Share (%), 2021
Figure 3.21 Global Erythropoietin Market by Application: Market Share (%), 2027
Figure 3.22 Global Anemia Forecast: Revenue ($m), AGR (%), 2015-2027
Figure 3.23 Global Kidney Disorders Forecast: Revenue ($m), AGR (%), 2015-2027
Figure 3.24 Global Others Forecast: Revenue ($m), AGR (%), 2015-2027
Figure 4.1 Global Erythropoietin API Manufacturing Forecast: Revenue ($m), AGR (%), 2015-2027
Figure 4.2 Global Erythropoietin API Manufacturing: Market Share (%), 2016
Figure 4.3 Global Erythropoietin API Manufacturing: Market Share (%), 2021
Figure 4.4 Global Erythropoietin API Manufacturing: Market Share (%), 2027
Figure 4.5 Global Contract Erythropoietin API Manufacturing Forecast: Revenue ($m), AGR (%), 2015-2027
Figure 4.6 Global In-House Erythropoietin API Manufacturing Forecast: Revenue ($m), AGR (%), 2015-2027
Figure 5.1 World Erythropoietin Market: Revenues ($m) by Region, 2015
Figure 5.2 World Erythropoietin Market: Revenues ($m) by Region, 2016
Figure 5.3 Global Erythropoietin Market Forecast: Revenue ($m), AGR (%), 2015-2027
Figure 5.4 World Erythropoietin Market: Market Shares (%) by Regional Market, 2016
Figure 5.5 World Erythropoietin Market: Market Shares (%) by Regional Market, 2021
Figure 5.6 World Erythropoietin Market: Market Shares (%) by Regional Market, 2027
Figure 6.1 North America Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 6.2 North America Erythropoietin Market: Market Shares (%) by Country, 2016
Figure 6.3 North America Erythropoietin Market: Market Shares (%) by Country, 2021
Figure 6.4 North America Erythropoietin Market: Market Shares (%) by Country, 2027
Figure 6.5 US Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 6.6 Canada Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 7.1 Europe Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 7.2 Europe Erythropoietin Market: Market Shares (%) by Country, 2016
Figure 7.3 Europe Erythropoietin Market: Market Shares (%) by Country, 2021
Figure 7.4 Europe Erythropoietin Market: Market Shares (%) by Country, 2027
Figure 7.5 Germany Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 7.6 France Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 7.7 U.K. Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 7.8 Italy Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 7.9 Spain Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 7.10 Rest of Europe Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 8.1 Asia Pacific Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 8.2 Asia Pacific Erythropoietin Market: Market Shares (%) by Country, 2016
Figure 8.3 Asia Pacific Erythropoietin Market: Market Shares (%) by Country, 2021
Figure 8.4 Asia Pacific Erythropoietin Market: Market Shares (%) by Country, 2027
Figure 8.5 China Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 8.6 Japan Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 8.7 India Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 8.8 Rest of Asia Pacific Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 9.1 Latin America Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 9.2 Latin America Erythropoietin Market: Market Shares (%) by Country, 2016
Figure 9.3 Latin America Erythropoietin Market: Market Shares (%) by Country, 2021
Figure 9.4 Latin America Erythropoietin Market: Market Shares (%) by Country, 2027
Figure 9.5 Brazil Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 9.6 Mexico Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 9.7 Rest of Latin America Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 10.1 Middle East and Africa Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 10.2 Middle East and Africa Erythropoietin Market: Market Shares (%) by Country, 2016
Figure 10.3 Middle East and Africa Erythropoietin Market: Market Shares (%) by Country, 2021
Figure 10.4 Middle East and Africa Erythropoietin Market: Market Shares (%) by Country, 2027
Figure 10.5 Saudi Arabia Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 10.6 South Africa Erythropoietin Market Forecast: Revenues ($m), AGR (%), 2015-2027
Figure 10.7 Rest of MEA Erythropoietin Market Forecast: Revenues ($m), AsGR (%), 2015-2027
Figure 11.1 Amgen, Inc.: Revenue ($m), AGR (%), 2011-2015
Figure 11.2 Johnson & Johnson: Revenue ($m), AGR (%), 2011-2015
Figure 11.3 Johnson & Johnson: Business Segment Revenue Share (%), 2015
Figure 11.4 Roche: Revenue ($m), AGR (%), 2011-2015
Figure 11.5 Roche: Business Segment Revenue Share (%), 2016
Figure 11.6 Biocon: Revenue ($m), AGR (%), 2012-2016
Figure 11.7 Biocon: Business Segment Revenue Share (%), 2016
Figure 11.8 3SBio: Revenue ($m), AGR (%), 2011-2015
Figure 11.9 3SBio: Business Segment Revenue Share (%), 2015
Figure 11.10 Pfizer, Inc.: Revenue ($m), AGR (%), 2011-2015
Figure 11.11 Pfizer, Inc.: Business Segment Revenue Share (%), 2015
Figure 11.12 Kyowa Hakko Kirin Co Ltd.: Revenue ($m), AGR (%), 2012-2016
Figure 11.13 Kyowa Hakko Kirin Co Ltd.: Pharmaceuticals Business Segment Revenue Share (%), 2015
Figure 11.14 LG Life Sciences Limited: Revenue ($m), AGR (%), 2011-2015
Figure 11.15 Novartis: Revenue ($m), AGR (%), 2012-2016
Figure 11.16 Novartis: Revenue, by Region, Share (%), 2016
Figure 12.1 Global Erythropoietin Market by Product Type: Market Share (%), 2016
Figure 12.2 Erythropoietin Market, By Region Share (%), 2016, 2021, 2027